Biomarkers and fine-tuned staging are key to progress in improving retinal care, according to Fanka Gilevska, MD, PhD.
Fanka Gilevska, MD, PhD
Advertisement
Articles by Fanka Gilevska, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Jay Chhablani, MD, reviews late-breaking findings from the ArMaDa trial
2
Nadia Waheed, MD, MPH: Transforming retinal disease imaging and clinical trials
3
Broader perspective for the treatment approach on retinal neovascular diseases
4
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved by FDA
5
